← Back to Clinical Trials
Recruiting NCT07924982

NCT07924982 Dento-skeletal Effects of Clear Twin Block Treatment at Specific Period in Growing Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07924982
Status Recruiting
Phase —
Sponsor University of Baghdad
Condition CLASS II DIVISION 1 MALOCCLUSION
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-10-20
Primary Completion 2027-01-25

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Digital twin block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-10-20 with a primary completion date of 2027-01-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Aim: To investigate the dento-skeletal effect of clear twin block in patients wearing the appliance at specific period. Methods: A total of 40 patients (regardless patients sex) with an age ranged from 9 to 12 years with class Ⅱ Div1 mal-occlusion and class 2 skeletal pattern will be included in the study. All the essential diagnostic records will be taken (for each patient) including: 1. Pre-operative and post-operative photographs. 2. Pre-operative and post-operative cephalometric radiographs. 3. Pre-operative and post-operative digital models. Another secondary records will be taken include: 1. Pre-operative hand and wrist radiograph. 2. Pre-operative and post-operative cone beam computed tomography (CBCT) Each patient will wear the appliance for 3 months with 16 hours per day wearing time. All patient's parents will assign an informed consent describing the treatment protocol. The following parameters will be assessed: 1. Over bite, over jet, inter-canine width and inter-molar width differences on digital models. 2. SNA, SNB, ANB, AO-BO and A-B Chang differences on lateral cephalometric radiographs. 3. Changes on condylar head and permanent first molar root resorption on CBCT.

Eligibility Criteria

Inclusion Criteria: * age ranged from 9 to 12 years * class Ⅱ Div1 mal-occlusion and class 2 skeletal pattern Exclusion Criteria: * Adults (passing the puberty) * Refuse to participate in the study * Uncooperative patients

Frequently Asked Questions

Who can join the NCT07924982 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying CLASS II DIVISION 1 MALOCCLUSION. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07924982 currently recruiting?

Yes, NCT07924982 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Baghdad to inquire about joining.

Where is the NCT07924982 trial being conducted?

This trial is being conducted at Baghdad, Iraq.

Who is sponsoring the NCT07924982 clinical trial?

NCT07924982 is sponsored by University of Baghdad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology